Novo Nordisk stock falls as multiple directors exit amid conflict over board composition

Core Insights - Novo Nordisk is experiencing significant corporate changes with the resignation of Chairman Helge Lund and six independent board members [1] Company Overview - Novo Nordisk is a leading Danish pharmaceutical company known for its successful weight loss drugs, Wegovy and Ozempic [1] Corporate Governance - The resignation of key figures in the company’s leadership raises questions about its governance and future direction [1]